A/G rs12983273 T/C(Continued)Breast Cancer: Targets and Therapy 2015:submit your manuscript | www.dovepress.comDovepressGraveel et alDovepressTable 2 (Continued)Gene locus MIR423 SNP rs6505162 A/C Comments premiRNA Population buy Conduritol B epoxide Caucasian Jewish BRCA2 carriers Asians Caucasians African Americans european Americans African Americans european Americans African Americans european Americans Chinese Asians Caucasians Asians Caucasians Chinese Caucasians Asians Caucasians Asians Caucasians Asians Caucasians African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans Asians Caucasians African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans Jewish BRCA2 carriers Caucasian italian Chinese Jewish BRCA1 carriers Chinese Clinical observation Reduced danger Later age of onset No threat association No threat association No danger association Decreased danger of eR+ BC No threat association elevated all round risk No threat association increased danger of eR- BC increased danger increased danger No risk association improved danger No danger association improved danger No threat association increased danger No danger association improved threat No risk association Decreased risk No threat association enhanced general danger No threat association No risk association enhanced general danger No danger association Decreased danger of eR+ BC elevated risk of eR- BC No risk association Decreased danger No threat association elevated risk of eR+ No danger association No danger association Decreased danger of eR- BC Decreased risk of eR+ BC No threat association Decreased risk of eR+ No threat association No threat association elevated overall danger Decreased general risk No danger association No threat association elevated danger of eR- BC increased risk improved threat increased danger increased danger in eR+ earlier age of onset increased danger (A allele) earlier age of onset (C allele) Decreased threat Decreased danger elevated risk Decreased survival Reference 150 142 38 33 33 33 36 151 152 32 147 153 31 141 33 33 33 33 141 33 33 33 33 33 33 33 142 srep39151 43 154 155 156 jir.2014.0227 157 158 159MIR455 MIR487 MIR495 MIRrs2060133 C/G rs1951032 G/A rs2281611 C/A rs3746444 A/Grs3746444 T/CMIR513A-2 MIR544 MIR548A-2 MIR595 MIR605 MIR606 MIR608 order Conduritol B epoxide MIRrs2018562 A/G rs10144193 A/T rs878175 A/G rs4909238 A/G rs2043556 *A rs12266981 G/A rs4919510 C/G rs8041885 A/G rs8041044 C/AMIR659 MIRrs5750504 T/A rs12586258 G/A rs7141987 A/GATF1 three UTR BMPR1B 3 UTR BRCA1 three UTR HPGD three UTR IGF-1R 3 UTR IL23R three UTRrs11169571 C/T rs1434536 C/T rs799917 C/T rs8752 G/A rs28674628 A/G rs10889677 A/CmiR320 MRe miR125b MRe miR638 MRe miR4855p MRe miR5155p MRe let7 MReIQGAP1 3 UTR ITGB4 3 UTRrs1042538 A/T rs743554 A/GmiR124 MRe miR34a MRepredictedChinese Swedish(Continued)submit your manuscript | www.dovepress.comBreast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable two (Continued)miRNA locus KRAS three UTR SNP rs61764370 T/G Comments let7 MRe Population Caucasian Clinical observation enhanced frequency in BRCA1 carriers/no risk association improved risk of TNBC Decreased threat increased threat and poor survival earlier age of onset enhanced risk elevated risk Decreased threat Decreased all round threat No danger association Decreased threat of eR+ BC No danger association increas.A/G rs12983273 T/C(Continued)Breast Cancer: Targets and Therapy 2015:submit your manuscript | www.dovepress.comDovepressGraveel et alDovepressTable 2 (Continued)Gene locus MIR423 SNP rs6505162 A/C Comments premiRNA Population Caucasian Jewish BRCA2 carriers Asians Caucasians African Americans european Americans African Americans european Americans African Americans european Americans Chinese Asians Caucasians Asians Caucasians Chinese Caucasians Asians Caucasians Asians Caucasians Asians Caucasians African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans Asians Caucasians African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans African Americans european Americans Jewish BRCA2 carriers Caucasian italian Chinese Jewish BRCA1 carriers Chinese Clinical observation Decreased threat Later age of onset No threat association No threat association No danger association Decreased threat of eR+ BC No threat association elevated all round risk No danger association elevated danger of eR- BC improved threat increased risk No danger association improved danger No risk association elevated threat No risk association improved danger No risk association enhanced risk No risk association Decreased threat No risk association enhanced general threat No danger association No danger association improved all round threat No risk association Decreased threat of eR+ BC elevated danger of eR- BC No danger association Decreased risk No threat association enhanced risk of eR+ No threat association No threat association Decreased risk of eR- BC Decreased danger of eR+ BC No threat association Decreased risk of eR+ No threat association No danger association increased general danger Decreased overall threat No risk association No threat association enhanced risk of eR- BC enhanced risk enhanced risk increased danger increased danger in eR+ earlier age of onset elevated risk (A allele) earlier age of onset (C allele) Decreased danger Decreased threat increased danger Reduced survival Reference 150 142 38 33 33 33 36 151 152 32 147 153 31 141 33 33 33 33 141 33 33 33 33 33 33 33 142 srep39151 43 154 155 156 jir.2014.0227 157 158 159MIR455 MIR487 MIR495 MIRrs2060133 C/G rs1951032 G/A rs2281611 C/A rs3746444 A/Grs3746444 T/CMIR513A-2 MIR544 MIR548A-2 MIR595 MIR605 MIR606 MIR608 MIRrs2018562 A/G rs10144193 A/T rs878175 A/G rs4909238 A/G rs2043556 *A rs12266981 G/A rs4919510 C/G rs8041885 A/G rs8041044 C/AMIR659 MIRrs5750504 T/A rs12586258 G/A rs7141987 A/GATF1 three UTR BMPR1B three UTR BRCA1 three UTR HPGD 3 UTR IGF-1R 3 UTR IL23R 3 UTRrs11169571 C/T rs1434536 C/T rs799917 C/T rs8752 G/A rs28674628 A/G rs10889677 A/CmiR320 MRe miR125b MRe miR638 MRe miR4855p MRe miR5155p MRe let7 MReIQGAP1 3 UTR ITGB4 three UTRrs1042538 A/T rs743554 A/GmiR124 MRe miR34a MRepredictedChinese Swedish(Continued)submit your manuscript | www.dovepress.comBreast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable two (Continued)miRNA locus KRAS three UTR SNP rs61764370 T/G Comments let7 MRe Population Caucasian Clinical observation increased frequency in BRCA1 carriers/no risk association elevated risk of TNBC Decreased danger enhanced threat and poor survival earlier age of onset increased threat enhanced threat Decreased risk Decreased overall danger No risk association Decreased threat of eR+ BC No threat association increas.
